Search

everythinglearnresearchcommunity

for

Search:↓

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

A new method for studying hair follicles is easier and more precise, useful for hair loss and cancer treatment research.

Porcine and human pilosebaceous units are very similar.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

Certain cancer drugs can cause skin issues like rashes and itching.

EREG therapy may help treat hair loss by promoting hair growth.

ZD1839 can cause skin issues like acne and hair changes.

Recurrent NICF is a rare skin condition with unclear causes, involving follicle inflammation and crystal deposits.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

A certain type of skin cell, marked by EGFR, produces a lot of IGF1 and helps hair follicles grow back faster.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Cross-section trichometry is an accurate method to measure hair loss and growth.

EGF and EGFR are important for goat skin development, increasing from weeks 6 to 21.

EGF and EGFR are essential for goat fetal skin development.

MLPH helps hair grow by activating IGF-1 signaling in hair cells.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

An extremely low-birthweight infant had a rare genetic skin disease and died despite treatment.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Inhibiting EGFR weakens skin's defense against bacteria.

EGFR-targeted cancer therapy can cause skin issues starting at hair follicles, leading to inflammation.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

EGFR helps protect hair follicles from bacterial infections.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.